Nick Bansback

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis (2009)

Guh, Daphne P, Zhang, Wei, Bansback, Nick, Amarsi, Zubin, Birmingham, C Laird, Anis, Aslam H

Abstract Background Overweight and obese persons are at risk of a number of medical conditions which can lead to further morbidity and mortality. The primary objective of this study is to provide an...

Economic evaluations in rheumatoid arthritis (2008)

Bansback, Nick, Ara, Roberta, Anis, Aslam, Karnon, Jonathan Daniel

We reviewed the clinical measures used in rheumatoid arthritis (RA) economic evaluations with respect to their relevance and sensitivity to changes in survival, health-related quality of life...

Economic evaluations in rheumatoid arthritis (2008)

Bansback, Nick, Ara, Roberta, Anis, Aslam, Karnon, Jonathan Daniel

We reviewed the clinical measures used in rheumatoid arthritis (RA) economic evaluations with respect to their relevance and sensitivity to changes in survival, health-related quality of life...

Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance (2008)

Wailoo, Allan, Bansback, Nick, Chilcott, Jim

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration (2008)

Karnon, Jonathan Daniel, Czoski-Murray, Carolyn, Smith, Kevin J., Brand, C., Chakravarthy, U., Davis, S., ...

http://www.ncbi.nlm.nih.gov/pubmed/18513468

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration (2008)

Karnon, Jonathan Daniel, Czoski-Murray, Carolyn, Smith, Kevin J., Brand, C., Chakravarthy, U., Davis, S., ...

http://www.ncbi.nlm.nih.gov/pubmed/18513468

“Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life? (2004)

Bansback, Nick, Ward, S., Karnon, Jonathan Daniel

The original publication can be found at www.springerlink.com

“Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life? (2004)

Bansback, Nick, Ward, S., Karnon, Jonathan Daniel

The original publication can be found at www.springerlink.com

Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States

Nick Bansback, Roberta Ara, Jonathan Karnon, Aslam Anis

We reviewed the clinical measures used in rheumatoid arthritis (RA) economic evaluations with respect to their relevance and sensitivity to changes in survival, health-related quality of life...

Impact of the recall period on measuring health utilities for acute events

Nick Bansback, Huiying Sun, Daphne P. Guh, Xin Li, Bohdan Nosyk, Susan Griffin, ...

The impact of healthcare interventions on health utility values is most frequently measured using a preference-based instrument. Each of the available instruments instructs the respondent to report...

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

Guh, Daphne P, Zhang, Wei, Bansback, Nick, Amarsi, Zubin, Birmingham, C Laird, Anis, Aslam H

Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis

Nick Bansback, Roberta Ara, Sue Ward, Aslam Anis, Hyon K. Choi

Background: HMG-CoA reductase inhibitors (statins) are potentially excellent candidate agents for patients with rheumatoid arthritis (RA). They reduce both cardiovascular risks and RA disease...